ProKidney
Highly Engaged Employees
Business Services · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2000 Frontis Plaza Blvd Ste 250, Winston...Phone Number
(336) 999-7019Website
www.prokidney.comRevenue
<$5 MillionStock Symbol
PROKIndustry
About ProKidney
ProKidney Org Chart
Is ProKidney your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ProKidney had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ProKidney
Earning: See what the market has to say on ProKidney recently announced quarterly report
Check if ProKidney has recently received funding, and reach out quickly before it becomes old news!
Check out if ProKidney is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ProKidney, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ProKidney has new funding data
Product Launch: Get notified when ProKidney launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at ProKidney
Find 3 more new buyers
Compare Similar Companies to ProKidney
Compare insights from companies similar to ProKidney, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ProKidney is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ProKidney is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProKidney.
ProKidney Tech Stack
A closer look at the technologies used by ProKidney
Most Recent Scoops
ProKidney News & Media
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
WINSTON-SALEM, N.C., May 15, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today reported financial results for the first quarter ended March 31, 2026, and provided business highlights.What Makes ProKidney Corp. (PROK) So Attractive
ProKidney Corp. (NASDAQ:PROK) is one of the 10 best penny stocks that could triple your money. On March 19, ProKidney Corp. (NASDAQ:PROK) announced fourth-quarter revenue of $893,000 against consensus estimates of $600,000. The company provided updates on its clinical progress and strategic priorities for advancing rilparencel through regulatory pathways. Chief Executive Officer Bruce Culleton stated […]ProKidney hires chief commercial officer as key results near - Winston-Salem Journal
ProKidney Corp. announced Thursday it has named Greg Madison as its chief commercial officer. He is responsible for leading ProKidney’s commercial strategy as the company advances towards the potential commercializationProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Veteran commercial executive brings deep nephrology and specialty biopharma leadership experience as ProKidney advances rilparencel toward potential commercialization Veteran commercial executive brings deep nephrology and specialty biopharma leadership experience as ProKidney advances rilparencel toward potential commercialization
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ProKidney
ProKidney, founded in 2015, is an advanced biotechnology company focused on research and development of pioneering medical therapies. The company specializes in innovative treatments designed to transform the medical landscape, with a particular focus on kidney-related therapies. Based in North America, ProKidney operates in the biotech sector, com... Read More